Silver Fiddle Therapy Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 19881 State Highway 88, Pine Grove, CA 95665 Phone: 209-560-6012 |
News Archive
Human Genome Sciences, Inc. today announced that it has received preliminary written feedback from the U.S. Food and Drug Administration (FDA) regarding the Company's Biologics License Application (BLA) seeking approval in the United States to market 900-mcg ZALBIN™ (albinterferon alfa-2b, known in Europe as JOULFERON®) dosed every two weeks for the treatment of chronic hepatitis C. FDA has expressed concerns regarding the risk benefit assessment of ZALBIN dosed at 900-mcg every two weeks.
Researchers from the University of Maryland School of Maryland report promising results from using adult stem cells from bone marrow in mice to help create tissue cells of other organs, such as the heart, brain and pancreas - a scientific step they hope may lead to potential new ways to replace cells lost in diseases such as diabetes, Parkinson's or Alzheimer's.
Over the past decade, researchers have learned that the hippocampus-historically known for its role in forming memories-is involved in much more than just remembering the past; it plays an important role in imagining events in the future.
A new fourth-generation oncolytic virus designed to both kill cancer cells and inhibit blood-vessel growth has shown greater effectiveness than earlier versions when tested in animal models of human brain cancer.
› Verified 1 days ago